# An in Vivo Bioequivalence Study of 2 Loxoprofen Sodium Products in Vietnamese Healthy Male Volunteers

> **NCT04386122** · PHASE1 · COMPLETED · sponsor: **Centre of Clinical Pharmacology, Hanoi Medical University** · enrollment: 24 (actual)

## Conditions studied

- Bioequivalence

## Interventions

- **DRUG:** FABALOFEN 60
- **DRUG:** JAPROLOX TABLET

## Key facts

- **NCT ID:** NCT04386122
- **Lead sponsor:** Centre of Clinical Pharmacology, Hanoi Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-07
- **Primary completion:** 2020-05-17
- **Final completion:** 2020-05-31
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2021-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04386122

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04386122, "An in Vivo Bioequivalence Study of 2 Loxoprofen Sodium Products in Vietnamese Healthy Male Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04386122. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*